What is wrong with cuffo narcotic samples?

If you take a glance at in the Daybook Of General Internal Medicine at face value, the next time your doctor gives you a drug customary from her desk drawer, you will decline it, even though the sample would save you chips that you and I both know you would appliance wisely.
Why end these authors motive caution in accepting comp samples? Because, their scan found, those costless handouts are generally not the choicest medications for your condition, that is, the samples doctors receive influence their prescribing habits, and doctors often substitute a standard that's at hand for another drug that would ordinarily be their first choice, a finding that will not suprise the pharmaceutical companies, of course, who spend millions of dollars giving out freebie samples to doctors precisely, I'm sure, because they know the samples do ascendancy doctors into prescribing those drugs.
Now, if you take that finding at face value, it might lead you to conclude that doctors are doing you harm by giving you the error drugs, so before I prompt kicked out of my doctors' union (oops! I mean, of course, "association," not union), for seeming to pick on my person MDs, let me quickly state that I don't accept that the practice of dispensing free ride samples is detrimental to your health.
First, handing out autonomous samples has at least one greater benefit: it often does save patients money. In the complimentary clinic where I used to practice, for example, the samples - birth control pills, antibiotics, etc. - were lifelines for some of our patients.
But added important, I think, is that handing elsewhere samples rarely causes harm because, with atypical exceptions, for the excessive majority of problems that make up a primary care practice, substituting one product for another usually makes petite difference in outcome. Why? Because, most current drugs are "me-too" products developed with apart one rationale in mind: to compete with a successfully marketed rival, and while these clones normally offer minor advantage over the established drug (newer SSRI antidepressants such as Paxil and Zoloft , for example, versus the older Prozac ), they infrequently offer much disadvantage either, although they do serve the valuable role of keeping drug prices down through healthier competition.

Keywords: